November 16, 2026 · Aesthetic plastic surgery · DOI: 10.1007/s00266-026-06347-4

Prophylactic Intralesional Botulinum Toxin Type A Versus Triamcinolone Acetonide Followed by Combination Therapy for Keloid Prevention and Treatment in High-Risk Orthopedic Surgery Patients: A Retrospective Comparative Study.

Listen to this summary

This retrospective study compared prophylactic intralesional botulinum toxin type A (BTX-A) with triamcinolone acetonide (TAC) in 74 keloid-prone patients undergoing orthopedic surgery, and assessed combined BTX-A+TAC therapy for those who developed keloids. Keloid formation rates were similar between groups, but BTX-A was associated with a longer time to formation and smaller lesion diameter, while TAC-prophylaxed patients responded better to subsequent combination therapy. The authors conclude that combined BTX-A+TAC is well tolerated and potentially effective for managing keloids in high-risk surgical patients, though the non-randomized design limits causal conclusions.

Anvar Ahmedov, Furkan Karabulut, Ali Can Çiçek, Mehmet Fatih Aksay

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play